4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-19-024500
Chairman and CEO bought 1,526 shares at an average $6.13 ($9,351)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KAZIMI A J Chairman and CEO | 2019-04-01 | Purchase | +382 | $5.99 | $2,288 | 5,759,656 | D |
| KAZIMI A J Chairman and CEO | 2019-04-02 | Purchase | +580 | $6.12 | $3,550 | 5,760,236 | D |
| KAZIMI A J Chairman and CEO | 2019-04-03 | Purchase | +80 | $6.00 | $480 | 5,760,316 | D |
| KAZIMI A J Chairman and CEO | 2019-04-04 | Purchase | +241 | $6.19 | $1,492 | 5,760,557 | D |
| KAZIMI A J Chairman and CEO | 2019-04-05 | Purchase | +183 | $6.32 | $1,157 | 5,760,740 | D |
| KAZIMI A J Chairman and CEO | 2019-04-09 | Purchase | +60 | $6.41 | $385 | 5,760,800 | D |
| Open-market purchases · 1,526 sh · avg $6.13 · $9,351 | |||||||
Loading xslF345X03/doc4.xml…